by Gary Finnegan: Six medicines, including two combination therapies for chronic hepatitis C, have been recommended for approval at the May meeting of the European Medicines Agency’s Committee for… read more.
by Gary Finnegan: The EU drug watchdog is reviewing the guidelines on first-in-human clinical trials in response to the tragic death of a participant in a trial in… read more.
by Gary Finnegan: Most successful applicants to the EU drug watchdog, the European Medicines Agency, have something in common: they seek scientific advice from the regulator when developing… read more.
by Gary Finnegan: Cholesterol levels – the most common risk factor for heart attacks – have decreased in northern Sweden over the last 20 years. Since medication only… read more.
by Gary Finnegan: Researchers in Finland have used computer modelling to estimate the true impact of infectious diseases, such as H1N1 (swine flu). Underreporting of cases means traditional… read more.
by Gary Finnegan: Exposing migraine sufferers to a narrow band of green light significantly reduces light sensitivity and can reduce headache severity, according to a new study led… read more.
by Gary Finnegan: Hospital admissions for first-time stroke increased in young adults in Denmark during the past two decades, according to new research in Journal of the American Heart… read more.
by Gary Finnegan: Cooperation between medicines regulators and health technology assessment (HTA) bodies is helping to streamline clinical studies of new medicines, according to a new report.
by Gary Finnegan: The European Medicines Agency (EMA) has published a draft version of a new paper on how to extrapolate clinical trial data from adults to children…. read more.
by Gary Finnegan: The European Medicines Agency (EMA) is coordinating a collective response to the medicines shortages which have plagued several European countries in recent years.
by Gary Finnegan: The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of seven new medicines, including one advanced therapy medicinal product (ATMP), at… read more.
by Gary Finnegan: Researchers have found that in over 3,000 Italian women with dense breasts where standard mammograms had not detected any cancer, the addition of tomosynthesis (a… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
